# US 2005/0033274 A1 · Apparatus and method for ablating tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0033274 A1
- Document ID: US20050033274A1
- Status: Published application
- Kind: A1
- Application number: 10/879,996
- Filed: 2004-06-28
- Published: 2005-02-10
- Earliest claimed: 1996-10-22
- Assignees: EPICOR MEDICAL, INC., A Delaware Corporation
- Inventors: Benjamin Pless; Scott Anderson; Jonathan Podmore; Matthias Vaska; John Crowe; Roxanne Richman; Timothy Ciciarelli; David Gallup; Jack Ulstad
- Web page: https://patentgrep.com/patent/US20050033274A1

## CPC

- A61B 17/22012: {in direct contact with, or very close to, the obstruction or concrement (for removing obstructions in blood vessels by laser A61B18/245)}
- A61B 17/2202: {the ultrasound transducer being inside patient's body at the distal end of the catheter}
- A61B 18/00: Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body (eye surgery A61F9/007; ear surgery A61F11/00)
- A61B 18/02: by cooling, e.g. cryogenic techniques
- A61B 18/1402: {Probes for open surgery}
- A61B 18/1482: {having a long rigid shaft for accessing the inner body transcutaneously in minimal invasive surgery, e.g. laparoscopy}
- A61N 1/06: for high-frequency therapy
- A61N 7/02: Localised ultrasound hyperthermia
- A61B 5/287: Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
- A61B 18/148: {having a short, rigid shaft for accessing the inner body transcutaneously, e.g. for neurosurgery or arthroscopy}
- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61B 34/20: Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
- A61B 2017/00039: {Electric or electromagnetic phenomena other than conductivity, e.g. capacity, inductivity, Hall effect}
- A61B 2017/00243: {cardiac}
- A61B 2017/00247: {Making holes in the wall of the heart, e.g. laser Myocardial revascularization}
- A61B 2017/00252: {for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel}
- A61B 2017/003: {Steerable}
- A61B 2017/22077: {with a part piercing the tissue (A61B2017/22044 takes precedence)}
- A61B 2017/3419: {Sealing means between cannula and body}
- A61B 2018/00023: {closed, i.e. without wound contact by the fluid}
- A61B 2018/0016: {Energy applicators arranged in a two- or three dimensional array}
- A61B 2018/00232: {having an irregular shape}
- A61B 2018/00261: {arranged in a line}
- A61B 2018/00285: {Balloons}
- A61B 2018/00291: {using suction}
- A61B 2018/00351: {Heart}
- A61B 2018/00363: {Epicardium}
- A61B 2018/00392: {Transmyocardial revascularisation}
- A61B 2018/00577: {Ablation}
- A61B 2018/00654: {with individual control of each of a plurality of energy emitting elements}
- A61B 2018/00797: {measured by multiple temperature sensors}
- A61B 2018/00839: {Bioelectrical parameters, e.g. ECG, EEG}
- A61B 2018/142: {at least partly surrounding the target, e.g. concave, curved or in the form of a cave}
- A61B 2018/1467: {using more than two electrodes on a single probe}
- A61B 2018/1472: {for use with liquid electrolyte, e.g. virtual electrodes}
- A61B 2090/3614: {using optical fibre}
- A61B 2090/3782: {transmitter or receiver in catheter or minimal invasive instrument}
- A61B 2090/395: {with marking agent for marking skin or other tissue}
- A61B 2218/002: Irrigation
- A61B 2218/007: Aspiration
- A61N 1/3629: {in combination with non-electric therapy}
- A61N 2007/0065: {Concave transducers}
- A61N 2007/0078: {with multiple treatment transducers}
- A61N 2007/027: {with multiple foci created simultaneously}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.

## Claims

### Claim at position 1

1-70 (Canceled).

### Claim 71

A device for ablating cardiac tissue, comprising:
a body having a longitudinal axis and a contact surface configured to be positioned adjacent tissue to be ablated;
a first transducer coupled to the body;
a second transducer coupled to the body and spaced apart from the first transducer by a space, wherein the first and second transducers each emit ultrasound energy to the tissue to be ablated; and
means for changing the direction of the ultrasound energy from the first transducer toward tissue beneath the gap between the first and second transducers.

### Claim 72 (depends on 71)

The device of claim 71, further comprising;
an inflatable membrane positioned beneath the first transducer to form the contact surface below the first transducer, the transducer moving upon inflation of the balloon.

### Claim 73

A method of ablating cardiac tissue, comprising the step of:
providing an ablating device including a body having a longitudinal axis and a contact surface, the ablating device also having a first transducer and a second transducer both coupled to the body, the second transducer being spaced apart from the first transducer by a gap, wherein the first and second transducers each emit ultrasound energy to the tissue to be ablated, the first transducer being movable to redirect the energy emitted by the first transducer to tissue beneath the gap between the first and second transducers;
positioning the ablating device against cardiac tissue;
activating the first and second transducers to ablate cardiac tissue;
moving the first transducer to ablate cardiac tissue beneath the gap between the first and second transducers.

### Claim 74 (depends on 73)

The method of claim 73, wherein:
the providing step is carried out with the body having an inflatable membrane beneath the first transducer; and
the pivoting step is carried out by inflating the balloon.

### Claim 75

A method of ablating a cardiac tissue, comprising the steps of:
providing an ablating device having a first transducer and a second transducer;
positioning the ablating device against cardiac tissue;
activating the first transducer at a first frequency to ablate cardiac tissue; and
activating the second transducer at a second frequency to ablate cardiac tissue.

### Claim 76 (depends on 75)

The method of claim 75, further comprising the step of:
moving the ablating device so that the activating steps are carried out to ablate the same cardiac tissue.

### Claim 77 (depends on 75)

The method of claim 75, wherein:
the activating steps are carried out to ablate different cardiac tissue.

### Claim 78 (depends on 75)

The method of claim 75, further comprising:
characterizing at least a portion of the cardiac tissue; and
selecting at least one of the first and second transducers to ablate the at least portion of the cardiac tissue based upon the characterizing step.

### Claim 79

A method of ablating a cardiac tissue, comprising the steps of:
providing an ablating device having a first transducer and a second transducer, the first and second transducers both being focused, the first and second transducers having different focal lengths;
positioning the ablating device against cardiac tissue;
activating the first transducer to ablate cardiac tissue; and
activating the second transducer.

### Claim 80 (depends on 79)

The method of claim 79, wherein:
the providing step is carried out with the first transducer having a first focal length and the second transducer has a second focal length different than the first focal length.

### Claim 81 (depends on 79)

The method of claim 79, wherein:
the providing step is carried out with the ablating device having a body, the first and second transducers being movable along the body.

### Claim 82 (depends on 81)

The method of claim 81, wherein:
the providing step is carried out with the first and second transducers being slidable along the body.

### Claim 83 (depends on 81)

The method of claim 81, further comprising the step of:
positioning the body at a selected location on an epicardial surface; and
moving the first and second transducers after the positioning step.

### Claim 84

A device for ablating tissue, comprising:
a body;
a source of focused ultrasound mounted to the body, the focused ultrasound having a focus; and
a flexible membrane filled with a substance which receives the focused ultrasound and transmits the ultrasound energy to the tissue.

### Claim 85 (depends on 36)

The device of claim 36, wherein:
the flexible membrane is inflatable to move the focus relative to the tissue to be ablated.

### Claim 86 (depends on 36)

The device of claim 36, wherein:
the flexible membrane tilts the body when inflated.

### Claim 87 (depends on 36)

The device of claim 36, wherein:
the source of focused ultrasound includes an ultrasound transducer.

### Claim 88

A system for ablating tissue with ultrasound energy, comprising:
an ablating element which emits ultrasound energy;
a control system coupled to the ablating element, the control system controlling activation of the ablating element to automatically change a characteristic of the ablating element when ablating the same tissue structure during a first time period and a second time period.

### Claim 89 (depends on 88)

The system of claim 88, wherein:
the control system is configured to automatically change a frequency of the ablating element.

### Claim 90 (depends on 88)

The system of claim 88, wherein:
the control system is configured to automatically change the power of the ablating element.

### Claim 91 (depends on 88)

The system of claim 88, wherein:
the ablating element emits focused ultrasound which is focused in at least one direction.

### Claim 92 (depends on 88)

The system of claim 88, wherein:
the control system automatically moves the focus relative to the tissue structure being ablated.

### Claim 93 (depends on 92)

The system of claim 92, wherein:
the control system moves the focus closer to a near surface of the tissue structure being ablated.

### Claim 94 (depends on 88)

The method of claim 88, wherein:
the control system includes means for assessing the adequacy of contact between the device and the tissue structure being ablated.

### Claim 95 (depends on 93)

The method of claim 93, wherein:
the assessing means is carried out by measuring an electrical impedance.

### Claim at position 27

96-106 (Canceled).

### Claim 107

A system for ablating tissue with ultrasound comprising the steps of:
an ablating device which emits focused ultrasound in at least one dimension; and
a control system operably coupled to the ablating device, the control system activating the ablating device at a frequency and a power to direct the ultrasonic energy into the tissue structure for a period of time, the control system also changing at least one of the frequency, power, period of time and location of the focus relative to the tissue.

### Claim 108 (depends on 107)

The system of claim 107, wherein:
the changing step is carried out to accumulate energy closer to a near surface of the tissue as compared to the operating step.

### Claim 109 (depends on 107)

The system of claim 107, wherein:
the changing step is carried out with the period of time increasing.

### Claim 110 (depends on 107)

The system of claim 107, wherein:
the changing step is carried out with the frequency increasing.

### Claim 111 (depends on 107)

The system of claim 107, further comprising:
means for assessing the contact between the ablating device and the tissue structure.

### Claim 112 (depends on 107)

The system of claim 107, further comprising:
means for measuring a tissue thickness using the ultrasonic transducer.

### Claim 113 (depends on 107)

The system of claim 107, wherein:
the first transducer has a first focal length and the second transducer has a second focal length different than the first focal length.

### Claim 114 (depends on 107)

The system of claim 107, wherein:
the ablating device has a body, the first and second transducers being slidably movable along the body.
